BIOMAT Database Logo BIOMAT Database Logo

Family study of serum lipids and lipoproteins in coronary heart-disease. 1973

E A Nikkilä, and A Aro

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females

Related Publications

E A Nikkilä, and A Aro
[Serum lipids, lipoproteins and coronary disease].
January 1972, Duodecim; laaketieteellinen aikakauskirja,
E A Nikkilä, and A Aro
Serum lipids and lipoproteins in children from families with early coronary heart disease.
January 1977, The Turkish journal of pediatrics,
E A Nikkilä, and A Aro
Serum lipids and lipoproteins in children from families with early coronary heart disease.
October 1972, Archives of disease in childhood,
E A Nikkilä, and A Aro
Serum lipoproteins and coronary heart disease.
October 1974, The American journal of cardiology,
E A Nikkilä, and A Aro
Lipids, lipoproteins and coronary heart disease in minority populations.
August 1994, Atherosclerosis,
E A Nikkilä, and A Aro
Correlation of serum lipids, lipoproteins, lipid peroxide products and metals with coronary heart disease.
March 1993, Chinese medical journal,
E A Nikkilä, and A Aro
Lipoproteins and lipids in diabetics with and without coronary heart disease.
September 1974, Journal of the Oslo city hospitals,
E A Nikkilä, and A Aro
Serum lipids and lipoproteins in patients with documented coronary artery disease.
July 2004, Pakistan journal of pharmaceutical sciences,
E A Nikkilä, and A Aro
Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapy.
June 1989, Cardiovascular drugs and therapy,
E A Nikkilä, and A Aro
Dietary oils, serum lipoproteins, and coronary heart disease.
June 1995, The American journal of clinical nutrition,
Copied contents to your clipboard!